|Market Maker Surveillance Report. IYR, IEF, ABUS, OPK, UVXY, VER, Bullishly Biased Price Friction For Wednesday, May 17th 2017|
|[ Release Date: 05/17/2017 18:45 PDT ]
May 17, 2017 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 4777 companies with "abnormal" market making, 1529 companies with positive Friction Factors and 5140 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bullish bias) in their stock prices. This means that there was more selling than buying in the stocks and their stock prices rose. iShares Dow Jones U.S. Real Estate Index Fund (NYSE:IYR), iShares Barclays 7-10 Year Treasury (NYSE:IEF), Arbutus Biopharma Corp (NASDAQ:ABUS), Opko Health Inc. (NASDAQ:OPK), PowerShares Exchange-Traded Fund Trust II (NYSE:UVXY), American Realty Capital Properties Inc. (NYSE:VER). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
Market Maker Friction Factor is shown in the chart below:
Symbol Change Percent Buy Volume Buy %% Sell Volume Sell %% Net Volume Friction
IYR $0.410 0.01% 2,139,478 25.83% 3,389,819 40.93% -1,250,341 Abnormal
IEF $0.850 0.01% 1,004,476 18.80% 3,043,926 56.97% -2,039,450 Abnormal
ABUS $0.100 0.03% 312,920 17.05% 1,226,929 66.86% -914,009 Abnormal
OPK $0.040 0.01% 2,086,812 30.46% 2,974,195 43.41% -887,383 Abnormal
UVXY $4.350 0.37% 25,444,821 28.85% 26,415,653 29.95% -970,832 Abnormal
VER $0.040 0.01% 2,357,525 28.42% 4,357,500 52.52% -1,999,975 Abnormal
Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above had more selling than buying on Wednesday and their stock prices rose. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.
For example, the chart above shows IYR with 1,250,341 greater shares of selling than buying (NetVol) and the stock price was up $0.41000. This means the Market Makers were trading the stock in a way inconsistent with normal supply and demand (Economics 101); more selling than buying should cause prices to drop.
iShares Dow Jones U.S. Real Estate Index Fund (NYSE:IYR) - ISHARE DJ R EST I.
iShares Barclays 7-10 Year Treasury (NYSE:IEF) - ISHARES LEHMAN 7-10.
Arbutus Biopharma Corp (NASDAQ:ABUS) - ANHEUSER BUSCH COS T.
Opko Health Inc. (NASDAQ:OPK) - OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel, and Mexico. The company s Diagnostics segment operates Bio-Reference Laboratories, a clinical laboratory that offers laboratory testing services in the detection, diagnosis, evaluation, monitoring, and treatment of diseases. The Bio-Reference Laboratories also provides core genetic testing and leverage products, such as the 4Kscore prostate cancer test and the Claros 1 in-office immunoassay platform. The company s pharmaceutical segment offers Rayaldee, a treatment for secondary hyperparathyroidism in adults with stage 3-4 chronic kidney disease patients with vitamin D deficiency; and VARUBI for chemotherapy-induced nausea and vomiting. This segment is also developing TT401, which is in Phase II clinical trials for type 2 diabetes and obesity; TT701, an androgen receptor modulator that is in Phase II clinical trials for androgen deficiency indications; and hGH-CTP, a growth hormone injection that is in Phase III clinical trials. In addition, it engages in developing and commercializing hGH-CTP, a recombinant human growth hormone product that is in Phase III; developing Factor VIIa drug for hemophilia that is in Phase IIa, an NK-1 compound, and drugs for treating asthma and chronic obstructive pulmonary disease; developing and producing specialty active pharmaceutical ingredients; discovery of drugs for the treatment of cancer, heart disease, metabolic disorders, and a range of genetic anomalies. Further, this segment engages in the development, manufacture, and sale of pharmaceutical, nutraceutical, and veterinary products; and markets and distributes pharmaceutical and natural products. Additionally, OPKO Health, Inc. operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was incorporated in 1991 and is headquartered in Miami, Florida..
PowerShares Exchange-Traded Fund Trust II (NYSE:UVXY) - .
American Realty Capital Properties Inc. (NYSE:VER) - .
BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"
Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING
Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports
Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks
Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups
SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Valuation - Tracks all known valuation models and applies them.
GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies.
PatternScan - Automates tracking of every technical pattern and predicts next move in stocks.
Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders
Events - Tracks patterns directly correlated to specific events.
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.
Content Managed by News-Articles.NET